We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TEI Biosciences Cited for Lax Monitoring, Adverse Event Reports
TEI Biosciences Cited for Lax Monitoring, Adverse Event Reports
Integra LifeScience’s TEI Biosciences drew a six-observation Form 483 from the FDA based on an inspection last October and November of the company’s facility in Boston, Mass.